Ever been told there is a “science” to making money? Three months, 59 trading sessions, less than $50 in commissions. That’s all it took for long investors to realize a 4,139% profit, 1,047% since December 1st alone. It’s crazy, but those with the foresight to put $500 into the penny stock of
Continue Reading →
5
JAN
0
Share
Although Gerald Commissiong, President & CEO of Amarantus BioSciences Inc. (AMBS), wasn’t the best Running Back while at Stanford, the PR “fumble” could be costly. Although they timed the good news with Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp. (RBCC), to come out before the market opened, they waited til the final whistle blew to close the markets ...
10
NOV
Share
NOV
Two weeks ago, Amarantus BioSciences Inc. (AMBS) issued a PR announcing positive behavioural efficacy data for their fight against Parkinson’s disease. Since then, when just 3 million shares were trading at a high of 0.0065, AMBS stock price has exploded exponentially gaining 764% in the process. Had it not been for patience and prior knowledge that any good ...
5
NOV
Share
NOV
